cefuroxime has been researched along with Obesity, Morbid in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cefuroxime is a well-established second-generation cephalosporin that is given preoperatively in surgery units at a standard dose of 1." | 2.74 | Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. ( Barbour, A; Ben-David, K; Burkhardt, O; Derendorf, H; Rout, WR; Schmidt, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbour, A | 1 |
| Schmidt, S | 1 |
| Rout, WR | 1 |
| Ben-David, K | 1 |
| Burkhardt, O | 1 |
| Derendorf, H | 1 |
1 trial available for cefuroxime and Obesity, Morbid
| Article | Year |
|---|---|
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
Topics: Abdomen; Adipose Tissue; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Chr | 2009 |